Industry strategies to reduce vector costs usually involve either ... in product approval delays due to raw material related regulatory challenges.” ...

The biopharmaceutical contract manufacturing market is expected to grow at a CAGR of 8.8% during the projected period. The ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and clinical studies and managing chemistry, manufacturing, and controls (CMC) ...